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Abstract
Introduction: Cutaneous metastases from carcinomas of the bladder are very rare. They are related to advanced
stages of the disease and have poor prognosis with low survival rates. The common treatment modality of
cutaneous metastases from a primary bladder cancer is wide local excision followed by chemotherapy.
Case presentation: We report a case of solitary skin metastasis from a rare type of urinary bladder carcinoma in a
68 year-old Caucasian man. Urinary bladder carcinoma metastasizing to the skin is an uncommon finding despite
the high incidence of this tumor. Skin metastasis generally presents in the late stages of this disease and indicates
a poor outcome.
Conclusions: Because of the extremely aggressive malignant potential of sarcomatoid carcinomas, the indications
for a transurethral resection of the bladder should be carefully assessed and suitable therapeutic strategies should
be examined further.
Introduction
The incidence of cutaneous metastasis from primary
urinary malignances is reported from 1.1% to 2.5%. The
most common are from kidney cancer (3.4-4%) followed
by urinary bladder cancer (0.84-3.6%) and prostate cancer
(0.36-0.7%) [1]. Usual sites of metastasis of urinary malig-
nancies include lung, bone, liver and regional nodes [2].
Very few cases of skin metastasizing from urinary bladder
are reported in the literature. This type of localization is
rare, generally presenting in the late stages of disease and
indicates a poor outcome. We report one case of cuta-
neous metastasis from sarcomatoid carcinoma of urinary
bladder, a very rare histological type, with metastatic
localization to the thoracic wall.
Case Presentation
A 68 year-old Caucasian man was admitted in our depart-
ment complaining of gross haematuria. A cystoscopic
examination found a 2.5 cm solid lesion located on the
posterior wall of the bladder. A total body Computed
Tomography (CT) scan was performed and showed a
bladder lesion with loco-regional node enlargement. The
CT scan revealed a hypodermic 38 × 22 mm nodular
lesion located on the right chest wall with increased
enhanced contrast (Figure 1). Cytological characterization
of this lesion was obtained with a fine needle aspiration
biopsy (FNAB) and “epithelial type cells with nuclear
atypia” were found. Considering the CT scan results and
the cytology report, a transurethral resection of the blad-
der (TURB) lesion was performed, along with surgical
resection of the chest wall nodule (Figure 2). The histolo-
gical diagnosis of the surgical specimen revealed sarcoma-
toid carcinoma invading the bladder musculature staged
pT3aN3M1 and graded G3 (Figure 3, Figure 4, Figure 5).
The skin lesion specimen showed poorly differentiated
neoplastic infiltration with morphologic aspects of urothe-
lial tissue with immunochemistry positivity for CK7 and
cerb-B2 and immunochemistry negativity for CK20
CD117 and TTF-1. The TURB specimen showed neoplas-
tic elements which were poorly differentiated, round and
spindle shaped and with a high mitotic index (70 mitosis/
10 HPF) (Figure 6). Small segments of these elements
demonstrated epithelial type immunochemistry (CK7 and
CK20 positive) whilst the major part of the neoplasm was
composed of sarcomatoid type differentiated cells positive
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for desmin and negative for cytokeratins. The immuno-
chemistry was also cromogranine A, smooth muscle actin,
CD3, CD20, CD117, EGFR negative. The proliferative
index evaluated with Ki67 was positive in the 60-70% of
the sarcomatoid cells and the Cerb-B2 was positive at
cytoplasmic membrane staining of the epithelial compo-
nent and was negative in the sarcomatoid component.
The histopathological report was summarized as an inva-
sive poorly differentiated bladder carcinoma metastasis
with a component of mixed, giant and spindle, sarcoma-
toid cells. Once recovered from surgeryg the patient
received four cycles of chemotherapy consisting of gemcy-
tabine, carboplatin and paclitaxel (Taxol). At six months
post-surgical follow-up, a repeat CT scan showed, despite
these treatments, a progression of loco-regional nodal dis-
ease and pulmonary metastasization.
Discussion
Cutaneous metastases are generally associated with car-
cinomas invading the bladder musculature(T3a) or to a
local advanced neoplasm (T3b/T4), although the litera-
ture reports a few cases of cutaneous metastasis in early
stage bladder cancer [3]. Presence of cutaneous localiza-
tion from urinary bladder cancer is highly correlated to
large metastatic disease [4]. Prognosis after cutaneous
metastasis appear generally poor with a median survival
of 13 to 14 monthsfor patients treated by chemotherapy,
although there is one sporadic case in the literature
reporting survival at 34 months [5,6]. Wide surgical
excision, as a curative and diagnostic attempt, is
Figure 1 CT scan showing a contrast enhanced hypodermic 38
× 22 mm nodular lesion on the right chest.
Figure 2 Surgical specimens of chest wall nodule.
Figure 3 Sarcomatoid invasion of the bladder muscularis/EE × 20.
Figure 4 Bladder round neoplastic elements/EE × 20.
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considered the first line procedure in these patients. In
the treatment of metastatic bladder cancer, single agent
chemotherapy using methotrexate, doxorubicin, vinblas-
tine or cisplatin produce response rates in 15 to 25% of
patients, whilst multiple agent chemotherapy treatment
increases this to 50 to 70% of cases[7]. The combination
of gemcytabin, paclitaxel and cisplatin produce response
rates in 78% of cases and a complete remission in 28%
of the patients producing a median survival rate of 24
months [8]. Alternative combinations of adjuvant thera-
pies are reported in the literature. Craig et al reports a
successful case with complete clinical resolution of two
metastatic skin lesions in a patient submitted to a cysto-
prostatectomy for bladder carcinoma, using local irradia-
tion [8]. Kubata et al also discuss a case of complete
resolution in a patient treated with bleomycin electro-
chemotherapy. [9]. Although we need to consider that a
non-operative clinical plan in these patients leads to cer-
tain disease progression, a single case in the literature
describes a case of cutaneous metastasis with sponta-
neous regression [10]. However, this unusual subtype of
cancer still remains a rare histological carcinoma variant
where pathological diagnosis is often very difficult with
a complex and extensive immunohistochemistry and
genetic pattern as described by Terada in his recent
publications [11,12].
The most prominent clinical characteristic of a sarco-
matoid carcinoma of the urinary bladder is the extreme
aggressive behavior. However, if the stage and the
patient’s clinical condition indicate surgery as appropri-
ate, then the therapy of choice will be a radical surgical
therapy. When surgery is not an option, palliation with
radiotherapy is indicated. Further studies are necessary
before we can make a conclusion on the therapeutic
strategies for sarcomatoid carcinomas of the bladder.
Conclusion
In conclusion, sarcomatoid carcinoma of the urinary blad-
der is a rare malignancy with a poor clinical prognosis. At
the present time, it seems appropriate to treat in the same
manner as conventional high-grade transitional cell carci-
noma (TCC) of the bladder with similar degrees of inva-
sion. In this group of patients it is important to recognize
the possibility of metastasis at uncommon sites. This con-
dition is highly correlated with an advanced oncological
staging or with an aggressive histopatological grading of
disease and indicates a very poor outcome for the patient.
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